Clinical Trial Update: Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction [Phase 2]

View source ↗

Summary

A Phase 2 trial update indicates that PSMA intensity can be altered by androgen signaling and phospho-Src obstruction in metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: St Vincent's Hospital, Sydney | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: COMPLETED